Debt-to-equity in % of IGC Pharma, Inc. from Q4 2011 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
IGC Pharma, Inc. quarterly Debt-to-equity history and change rate from Q4 2011 to Q3 2025.
  • IGC Pharma, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 32.7 %, a 1.42% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

IGC Pharma, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 32.7 -0.47 -1.42% 30 Sep 2025
Q2 2025 38.8 +12.9 +50% 30 Jun 2025
Q1 2025 39.3 +17.2 +77.5% 31 Mar 2025
Q4 2024 38.5 +20.3 +111% 31 Dec 2024
Q3 2024 33.2 +18.5 +126% 30 Sep 2024
Q2 2024 25.8 +13.4 +107% 30 Jun 2024
Q1 2024 22.1 +11.6 +110% 31 Mar 2024
Q4 2023 18.2 +8.01 +78.3% 31 Dec 2023
Q3 2023 14.7 +5.6 +61.5% 30 Sep 2023
Q2 2023 12.5 +3.6 +40.6% 30 Jun 2023
Q1 2023 10.6 +1.93 +22.4% 31 Mar 2023
Q4 2022 10.2 +2.12 +26.1% 31 Dec 2022
Q3 2022 9.1 -0.32 -3.4% 30 Sep 2022
Q2 2022 8.87 -1.36 -13.3% 30 Jun 2022
Q1 2022 8.63 -2.99 -25.7% 31 Mar 2022
Q4 2021 8.11 -3.62 -30.8% 31 Dec 2021
Q3 2021 9.42 -0.08 -0.84% 30 Sep 2021
Q2 2021 10.2 +2.36 +30% 30 Jun 2021
Q1 2021 11.6 +6.21 +115% 31 Mar 2021
Q4 2020 11.7 +7.85 +202% 31 Dec 2020
Q3 2020 9.49 +6.34 +201% 30 Sep 2020
Q2 2020 7.87 +3.3 +72.2% 30 Jun 2020
Q1 2020 5.41 -3.52 -39.4% 31 Mar 2020
Q4 2019 3.89 -11.4 -74.5% 31 Dec 2019
Q3 2019 3.15 -32.9 -91.3% 30 Sep 2019
Q2 2019 4.57 -44.4 -90.7% 30 Jun 2019
Q1 2019 8.93 -40.4 -81.9% 31 Mar 2019
Q4 2018 15.3 -39.6 -72.2% 31 Dec 2018
Q3 2018 36.1 -17.8 -33% 30 Sep 2018
Q2 2018 48.9 +6.73 +16% 30 Jun 2018
Q1 2018 49.4 +10.5 +26.9% 31 Mar 2018
Q4 2017 54.9 +18.8 +52.3% 31 Dec 2017
Q3 2017 53.9 +19.5 +56.7% 30 Sep 2017
Q2 2017 42.2 +5.95 +16.4% 30 Jun 2017
Q1 2017 38.9 +1.13 +2.99% 31 Mar 2017
Q4 2016 36 -2.46 -6.39% 31 Dec 2016
Q3 2016 34.4 -2.71 -7.31% 30 Sep 2016
Q2 2016 36.2 -0.63 -1.71% 30 Jun 2016
Q1 2016 37.8 +4.33 +12.9% 31 Mar 2016
Q4 2015 38.5 +7.97 +26.1% 31 Dec 2015
Q3 2015 37.1 +7.34 +24.7% 30 Sep 2015
Q2 2015 36.9 +8.44 +29.7% 30 Jun 2015
Q1 2015 33.5 +5.05 +17.8% 31 Mar 2015
Q4 2014 30.5 +1.29 +4.42% 31 Dec 2014
Q3 2014 29.8 -2.35 -7.32% 30 Sep 2014
Q2 2014 28.4 -12.2 -30% 30 Jun 2014
Q1 2014 28.4 -21.1 -42.6% 31 Mar 2014
Q4 2013 29.2 -28.8 -49.6% 31 Dec 2013
Q3 2013 32.1 -49 -60.4% 30 Sep 2013
Q2 2013 40.6 -50.1 -55.2% 30 Jun 2013
Q1 2013 49.5 -51.7 -51.1% 31 Mar 2013
Q4 2012 58 -63.4 -52.2% 31 Dec 2012
Q3 2012 81.1 30 Sep 2012
Q2 2012 90.7 30 Jun 2012
Q1 2012 101 31 Mar 2012
Q4 2011 121 31 Dec 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.